On April 25, 2024, OncoCyte Corporation closed the transaction. The transaction included participation from 21 investors pursuant to Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.07 USD | +4.07% | +6.97% | +22.80% |
15/05 | Transcript : OncoCyte Corporation, Q1 2024 Earnings Call, May 15, 2024 | |
15/05 | Earnings Flash (OCX) ONCOCYTE CORPORATION Reports Q1 Revenue $176,000, vs. Street Est of $0.4M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.80% | 41.03M | |
+8.29% | 114B | |
+10.21% | 104B | |
+0.70% | 22.28B | |
-11.90% | 22.41B | |
-5.20% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- OCX Stock
- News OncoCyte Corporation
- OncoCyte Corporation announced that it has received $15.807655 million in funding